Definition of the NANDA label
Yellow-orange coloration of the skin and mucous membranes of the neonate that appears at 24 hours of life as a result of the presence of unconjugated bilirubin in the blood.
The accumulation of unconjugated bilirubin in the circulation (less than 15 ml/dl) that occurs after 24 hours of life.
• Abnormal blood profile (hemolysis, total serum bilirubin> 2mg / dl; total serum bilirubin in high-risk-for-age range on specific normogram).
• Abnormal bruising on the skin.
• Yellow-orange skin.
• Yellow sclera.
• Abnormal weight loss (> 7-8% in the breastfed neonate; 15% in the term neonate).
• Poorly established eating pattern.
• The newborn has difficulty making the transition to extrauterine life.
• Age of the newborn 1-7 days.
• Delayed elimination of stool (meconium).
At risk population
• ABO incompatibility
• Age ≤ 7 days
• American Indian ethnicity
• Blood type incompatibility between mother and infant – East Asian ethnicity
• Infant who is breastfed
• Infant with low birthweight
• Maternal diabetes mellitus
• Populations living at high altitudes
• Premature infant
• Previous sibling with jaundice
• Rhesus (Rh) incompatibility
• Significant bruising during birth
• Bacterial infection
• Infant with liver malfunction
• Infant with enzyme deficiency
• Internal bleeding
• Prenatal infection
• Viral infection
• Role of being parents.
• Specific care.
• Correct disposal.
• Favor family support.
• Promotion of the role.
• Perinatal care.
• Neonatal care.